{
    "eid": "2-s2.0-85096649035",
    "title": "Angiotensin Receptor Blockers in cyclodextrin nanoparticle eye drops: Ocular pharmacokinetics and pharmacologic effect on intraocular pressure",
    "cover-date": "2021-06-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Ophthalmology",
            "@code": "2731",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "angiotensin receptor blockers",
        "glaucoma",
        "intraocular pressure",
        "pharmacokinetics"
    ],
    "authors": [
        "Laura Lorenzo-Soler",
        "Olof Birna Olafsdottir",
        "Gerhard Garh\u00f6fer",
        "Phatsawee Jansook",
        "Iris Myrdal Kristinsdottir",
        "Aimin Tan",
        "Thorsteinn Loftsson",
        "Einar Stefansson"
    ],
    "citedby-count": 10,
    "ref-count": 28,
    "ref-list": [
        "Mechanisms of angiotensin converting enzyme inhibitor-induced IOP reduction in normotensive rats",
        "Angiotensin receptor blockers - Advantages of the new sartans",
        "Regulation of intraocular pressure after water drinking",
        "Angiotensin II receptor blockers",
        "Clinical relevance of local renin angiotensin systems",
        "Pharmacokinetics and intraocular pressure lowering effect of timolol preparations in rabbit eyes",
        "Effect of oral captopril (SQ 14225) on intraocular pressure in man",
        "Intraocular pressure in rabbits by telemetry II: Effects of animal handling and drugs",
        "Ocular drug distribution after topical administration: population pharmacokinetic model in rabbits",
        "Differential effects of angiotensin II type I receptor blockers on reducing intraocular pressure and TGF \u03b2 signaling in the mouse retina",
        "Local ocular renin\u2013angiotensin\u2013aldosterone system: any connection with intraocular pressure? A comprehensive review",
        "Effect of oral losartan potassium administration on intraocularpressure in normotensive and glaucomatous human subjects",
        "Managing adverse effects of glaucoma medications",
        "The effect of topical CS-088, an angiotensin AT1 receptor antagonist, on intraocular pressure and aqueous humor dynamics in rabbits",
        "Development of eye drops containing antihypertensive drugs: Formulation of aqueous irbesartan/\u03b3CD eye drops",
        "Topical drug delivery to the posterior segment of the eye: Dexamethasone concentrations in various eye tissues after topical administration for up to 15 days to rabbits",
        "Inhibitory effects of angiotensin II receptor blockade on human tenon fibroblast migration and reactive oxygen species production in cell culture",
        "Intraocular toxicity and pharmacokinetics of candesartan in a rabbit model",
        "Enalaprilat and enalapril maleate eyedrops lower intraocular pressure in rabbits",
        "Repeatability, reproducibility and agreement of intraocular pressure measurement in rabbits by the TonoVet and Tono-Pen",
        "Clinical pharmacokinetics of the eye. Proctor lecture",
        "Effect of \u03b3-cyclodextrin on solubilization and complexation of irbesartan: Influence of pH and excipients",
        "Ocular drug delivery systems: An overview",
        "Comparison of the AT1-receptor blockers candesartan, irbesartan and losartan for inhibiting renal microvascular constriction",
        "Trachoma, antibiotics and randomised controlled trials",
        "The renin-angiotensin",
        "Topical ocular hypotensive effects of the novel angiotensin converting enzyme inhibitor SCH 33861 in conscious rabbits",
        "Diurnal variations in intraocular pressure"
    ],
    "affiliation": [
        {
            "affiliation-city": "Reykjavik",
            "@id": "60071132",
            "affilname": "Landspitali - The National University Hospital of Iceland",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071132",
            "affiliation-country": "Iceland"
        },
        {
            "affiliation-city": "Reykjavik",
            "@id": "60071115",
            "affilname": "L\u00e6knadeild H\u00e1sk\u00f3la \u00cdslands",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071115",
            "affiliation-country": "Iceland"
        },
        {
            "affiliation-city": "Reykjavik",
            "@id": "60071113",
            "affilname": "Haskoli Islands",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071113",
            "affiliation-country": "Iceland"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Vienna",
            "@id": "60011394",
            "affilname": "Medizinische Universit\u00e4t Wien",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60011394",
            "affiliation-country": "Austria"
        },
        {
            "affiliation-city": "Reykjavik",
            "@id": "124573322",
            "affilname": "Oculis ehf",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/124573322",
            "affiliation-country": "Iceland"
        },
        {
            "affiliation-city": "Toronto",
            "@id": "114117678",
            "affilname": "Nucro-Technics",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/114117678",
            "affiliation-country": "Canada"
        }
    ],
    "funding": []
}